VERTEX PHARMACEUTICALS INC / MA — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$3.63B
Free Cash Flow
$3.19B
Investing Cash Flow
$-945M
Financing Cash Flow
$-2.26B
Capex
$438M
Acquisitions
$0
Stock Buybacks
$2.02B
Stock-Based Comp
$686M
Debt Issued
—
Debt Repaid
—
D&A
$210M
SBC Allocated Expense
$686M
SBC Unrecognized Cost
$742M